100 related articles for article (PubMed ID: 10682709)
21. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum.
Le Moine C; Bloch B
J Comp Neurol; 1995 May; 355(3):418-26. PubMed ID: 7636023
[TBL] [Abstract][Full Text] [Related]
22. Dopaminergic control of gene transcription during striatal ontogeny: c-fos induction by D1 receptor activation in the developing striosomes.
Arnauld E; Arsaut J; Tafani JA; Demotes-Mainard J
Brain Res Mol Brain Res; 1995 Jun; 30(2):223-32. PubMed ID: 7637573
[TBL] [Abstract][Full Text] [Related]
23. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
[TBL] [Abstract][Full Text] [Related]
24. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
Hervé D; Le Moine C; Corvol JC; Belluscio L; Ledent C; Fienberg AA; Jaber M; Studler JM; Girault JA
J Neurosci; 2001 Jun; 21(12):4390-9. PubMed ID: 11404425
[TBL] [Abstract][Full Text] [Related]
25. Striatal Neurons Expressing D
Gagnon D; Petryszyn S; Sanchez MG; Bories C; Beaulieu JM; De Koninck Y; Parent A; Parent M
Sci Rep; 2017 Jan; 7():41432. PubMed ID: 28128287
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
[TBL] [Abstract][Full Text] [Related]
27. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
28. Adaptive gene expression changes on the healthy side of parkinsonian rats.
Capper-Loup C; Frey CM; Rebell D; Kaelin-Lang A
Neuroscience; 2013 Mar; 233():157-65. PubMed ID: 23270858
[TBL] [Abstract][Full Text] [Related]
29. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
Robertson GS; Vincent SR; Fibiger HC
Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
[TBL] [Abstract][Full Text] [Related]
30. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.
Le Moine C; Bloch B
Neuroscience; 1996 Jul; 73(1):131-43. PubMed ID: 8783237
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
32. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
33. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs.
Frohna PA; Neal-Beliveau BS; Joyce JN
Neuroscience; 1995 Sep; 68(2):505-18. PubMed ID: 7477961
[TBL] [Abstract][Full Text] [Related]
34. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.
Radja F; el Mansari M; Soghomonian JJ; Dewar KM; Ferron A; Reader TA; Descarries L
Neuroscience; 1993 Dec; 57(3):635-48. PubMed ID: 7906013
[TBL] [Abstract][Full Text] [Related]
35. Ontogeny of the D1 dopamine receptor in the rat striatonigral system: an immunohistochemical study.
Caille I; Dumartin B; Le Moine C; Begueret J; Bloch B
Eur J Neurosci; 1995 Apr; 7(4):714-22. PubMed ID: 7620620
[TBL] [Abstract][Full Text] [Related]
36. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
[TBL] [Abstract][Full Text] [Related]
37. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.
Diaz J; Lévesque D; Lammers CH; Griffon N; Martres MP; Schwartz JC; Sokoloff P
Neuroscience; 1995 Apr; 65(3):731-45. PubMed ID: 7609872
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.
Tomiyama K; Kim HA; Kinsella A; Ehrlich ME; Schütz G; Koshikawa N; Lawrence AJ; Waddington JL; Drago J
Synapse; 2011 Sep; 65(9):835-42. PubMed ID: 21308794
[TBL] [Abstract][Full Text] [Related]
39. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
Haber SN; Ryoo H; Cox C; Lu W
J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
[TBL] [Abstract][Full Text] [Related]
40. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
